Marco Trucco. “Two Cases of New Daily Persistent Headache Successfully Treated With Onabotulinum Toxin Type A (BoNT-A)”. Current Innovations in Medicine and Medical Science Vol. 7, Nov. 2022, pp. 169-78, doi:10.9734/bpi/cimms/v7/4654A.